Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
| Country | United States |
|---|---|
| Deadline | Not published |
| Published | 2023-11-24 |
| Sectors | IT, software & digital, Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity FOR-FD-24-003. CFDA: 93.103
The buyer, the value, the full description and the link to the official notice are available with a free account.